Ganaplacide clinical trials
Also written KAF156.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How each study uses ganaplacide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
7 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2021 | 2 |
| 2022 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses ganaplacide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum MalariaCompletedPhase 2Novartis PharmaceuticalsNCT04546633Written as KAF156
- Drug-drug Interaction Study of Ganaplacide and Lumefantrine With EfavirenzCompletedPhase 1Novartis PharmaceuticalsNCT05330273Written as Ganaplacide
- Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and DolutegravirCompletedPhase 1Novartis PharmaceuticalsNCT05236530Written as Ganaplacide
- Drug-drug Interaction Study of Ganaplacide and Lumefantrine With ItraconazoleCompletedPhase 1Novartis PharmaceuticalsNCT05084651Written as Ganaplacide
- Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum MalariaCompletedPhase 2Novartis PharmaceuticalsNCT03167242Written as KAF156
- Safety and Causal Prophylactic Efficacy of KAF156 in a Controlled Human Malaria Challenge ModelCompletedPhase 1Novartis PharmaceuticalsNCT04072302Written as KAF156
- Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infectionCompletedPhase 2Novartis PharmaceuticalsNCT01753323Written as KAF156
Codes
What other systems call ganaplacide · ClinicalTrials.gg INT000278
- MeSH (NLM) C000599914ganaplacideOne source NLM
- UNII (FDA) 85VMN9JU7AGANAPLACIDEConfirmed FDA, NLM, Wikidata
- Wikidata Q28209255ganaplacideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C175070GanaplacideOne source FDA
- DrugBank DB16173One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000599914 | ganaplacide | One source NLM |
| UNII (FDA) | 85VMN9JU7A | GANAPLACIDE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q28209255 | ganaplacide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C175070 | Ganaplacide | One source FDA |
| DrugBank | DB16173 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.